(Q54320621)
Statements
Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors. (English)
1 reference
Lorenza Landi
Rita Chiari
Serena Ricciardi
Elisa Rossi
Silvia Novello
Michele Milella
Armida D'Incecco
Gabriele Minuti
Carmelo Tibaldi
Jessica Salvini
Francesco Facchinetti
Eva Regina Haspinger
Antonio Santo
Giuseppe Banna
Annamaria Catino
Matteo GiajLevra
Lucio Crinò
Filippo de Marinis
16 August 2014
1 reference